<- Go Home

CellaVision AB (publ)

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company’s CellaVision Bone Marrow Aspirate Application enables laboratories to automate, standardize, and simplify morphological examination of bone marrow aspirate samples; CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas, a library of blood cell images and descriptions created by digital cell morphology experts; CellaVision Review Software removes restrictive constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.

Market Cap

SEK 3.1B

Volume

26.6K

Cash and Equivalents

SEK 230.2M

EBITDA

SEK 194.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 496.7M

Profit Margin

67.98%

52 Week High

SEK 202.50

52 Week Low

SEK 117.60

Dividend

2.14%

Price / Book Value

3.35

Price / Earnings

22.84

Price / Tangible Book Value

4.30

Enterprise Value

SEK 2.9B

Enterprise Value / EBITDA

13.83

Operating Income

SEK 173.5M

Return on Equity

15.30%

Return on Assets

9.95

Cash and Short Term Investments

SEK 230.2M

Debt

SEK 22.4M

Equity

SEK 914.3M

Revenue

SEK 730.6M

Unlevered FCF

SEK 89.9M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches